Amedeo's Top 20

Amedeo Smart

Independent Medical Education


04 January 2021

Multidisciplinary Journal Club

  1. Overton ET, Richmond G, Rizzardini G, Jaeger H, et al.
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet 2021;396:1994-2005.

  1. Cavallieri F, Fraix V, Bove F, Mulas D, et al.
    Predictors of long-term outcome of subthalamic stimulation in Parkinson disease.
    Ann Neurol 2020.

  2. Rajan KB, Aggarwal NT, McAninch EA, Weuve J, et al.
    Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study.
    Ann Neurol 2020;88:1065-1076.

  3. Lee SY, Pearce EN.
    Testing, Monitoring, and Treatment of Thyroid Dysfunction in Pregnancy.
    J Clin Endocrinol Metab 2020.

  4. Sana F, Isselbacher EM, Singh JP, Heist EK, et al.
    Wearable Devices for Ambulatory Cardiac Monitoring: JACC State-of-the-Art Review.
    J Am Coll Cardiol 2020;75:1582-1592.

  1. Thirion PG, Dunne MT, Kelly PJ, Flavin A, et al.
    Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.
    Br J Cancer 2020;122:1315-1323.

  2. Iacucci M, Smith SC, Bazarova A, Shivaji UN, et al.
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology 2020.

  3. Otto CM, Nishimura RA, Bonow RO, Carabello BA, et al.
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol 2020.

  4. Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, et al.
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med 2020;26:1691-1693.

  5. Beltran-Garcia J, Osca-Verdegal R, Pallardo FV, Ferreres J, et al.
    Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches.
    Crit Care Med 2020.

  1. Davis KAS, Bishara D, Perera G, Molokhia M, et al.
    Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta-Analysis.
    J Am Geriatr Soc 2020;68:650-658.

  2. Lacy SE, Barrans SL, Beer PA, Painter D, et al.
    Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
    Blood 2020;135:1759-1771.

  3. Xu L, Su H, She Y, Dai C, et al.
    Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: the number of involved nodal stations versus the location-based pathological N stage?
    Chest 2020.

  4. Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, et al.
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis 2020.

  5. Wei HJ, Upadhyayula PS, Pouliopoulos AN, Englander ZK, et al.
    Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment.
    Int J Radiat Oncol Biol Phys 2020.

  1. .
    Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
    Cancer 2020.

  2. Tamama K.
    Potential benefits of dietary seaweeds as protection against COVID-19.
    Nutr Rev 2020.

  3. McMahon DK, Zheng L, Cyktor JC, Aga E, et al.
    A phase I/II randomized, placebo-controlled trial of romidepsin in persons with HIV-1 on suppressive antiretroviral therapy to assess safety and activation of HIV-1 expression (A5315).
    J Infect Dis 2020.

  4. Hammer M, Santer P, Schaefer MS, Althoff FC, et al.
    Supraglottic airway device versus tracheal intubation and the risk of emergent postoperative intubation after general anaesthesia in adults: a retrospective cohort study.
    Br J Anaesth 2020.

  5. Orkin C, Squires KE, Molina JM, Sax PE, et al.
    Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 %0
    Clin Infect Dis 2020.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016